FDA Approved: CLEVIPREX — Supplemental Application (Fresenius Kabi Austria GmbH)

View source ↗

Summary

FDA approved a supplemental application for CLEVIPREX (clevidipine) from Fresenius Kabi Austria GmbH. The action involves a labeling/indication update submitted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Hypertensive Emergency

Drugs mentioned

• CLEVIPREX (clevidipine)

Snippet

SUPPL AP for CLEVIPREX (CLEVIDIPINE)